SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000947871-17-000701
Filing Date
2017-09-07
Accepted
2017-09-07 14:20:45
Documents
2
Group Members
ORBIMED CAPITAL GP VI LLCSAMUEL D. ISALY

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D ss58047_sc13d.htm SC 13D 117845
2 JOINT FILING AGREEMENT ss58047_ex9901.htm EX-99.1 21062
  Complete submission text file 0000947871-17-000701.txt   140561
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13D

Mailing Address 200 SIDNEY STREET SUITE 320 CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET SUITE 320 CAMBRIDGE MA 02139 617-401-9975
SYNLOGIC, INC. (Subject) CIK: 0001527599 (see all company filings)

IRS No.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-89131 | Film No.: 171073596
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1